Beyond the development of quality-of-life instruments: where do we go from here?

Editorial

Mark N Levine et al. J Clin Oncol. 2002.

. 2002 May 1;20(9):2215-6.

doi: 10.1200/JCO.2002.20.9.2215.

No abstract available

Comment in

Do quality-of-life randomized clinical trials support clinicians in their decision-making?
Efficace F, Bottomley A. Efficace F, et al. J Clin Oncol. 2002 Oct 1;20(19):4126-7; author reply 4127. doi: 10.1200/JCO.2002.99.117. J Clin Oncol. 2002. PMID: 12351614 No abstract available.
Quality-of-life meta-analysis: why treat it differently?
Sloan JA. Sloan JA. J Clin Oncol. 2003 Apr 1;21(7):1422. doi: 10.1200/JCO.2003.99.037. J Clin Oncol. 2003. PMID: 12663740 No abstract available.
Surrogate outcomes in quality-of-life research: where will we end up?
Tassinari D, Panzini I, Sartori S, Ravaioli A. Tassinari D, et al. J Clin Oncol. 2003 May 1;21(9):1894-5; author reply 1895. doi: 10.1200/JCO.2003.99.244. J Clin Oncol. 2003. PMID: 12721275 No abstract available.

Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.
Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L. Heffernan N, et al. J Clin Oncol. 2002 May 1;20(9):2229-39. doi: 10.1200/JCO.2002.07.093. J Clin Oncol. 2002. PMID: 11980994